Keywords:
metabolic syndrome, hs-CRP, inflammation, subclinical atherosclerosis, cardiovascular risk.References
Kirichenko Andrey Apollonovich, Polyakova Olga Alexandrovna, & Dubovskaya Irina Nikolaevna (2021). Levels of highly sensitive c-reactive protein in working young and middle-aged men. Consilium Medicum, 23 (1), 99-102.
Koziarska-Rościszewska M., Podgórski M., Chudzik M., et al. High-sensitivity C-reactive protein relationship with metabolic syndrome and its components in hypertensive patients. Life (Basel). 2021;11 (8):742.
Mazidi M., Toth P.P., Banach M. C-reactive protein is associated with the prevalence of metabolic syndrome, hypertension, and diabetes mellitus in US adults. Angiology. 2018;69 (5):438-442.
Mirhafez S.R., Ebrahimi M., Saberi Karimian M., et al. High-sensitivity serum C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects. European Journal of Clinical Nutrition. 2016;70 (11):1298-1304.
Shah A.D., Langenberg C., Rapsomaniki E., et al. Type 2 diabetes and CVD risk: a linked electronic health record cohort study. Lancet Diabetes Endocrinol. 2015;3 (2):105-113.
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W.,... & Tsao, C. W. (2021). Heart disease and stroke statistics - 2021 update: a report from the American Heart Association. Circulation, 143 (8), e254-e743. doi:10.1161/CIR.00000000 00000950
World Health Organization. Cardiovascular diseases (CVD). Fact sheet. Geneva: WHO; 2023.